Logo image of ANSC

AGRICULTURE & NATURAL SOLUTI (ANSC) Stock Fundamental Analysis

NASDAQ:ANSC - KYG0131Y1008 - Common Stock

10.9 USD
+0.02 (+0.18%)
Last: 8/27/2025, 10:31:15 AM
11.2 USD
+0.3 (+2.75%)
After Hours: 8/6/2025, 8:08:36 PM
Fundamental Rating

1

Taking everything into account, ANSC scores 1 out of 10 in our fundamental rating. ANSC was compared to 0 industry peers in the Unkown industry. ANSC has a bad profitability rating. Also its financial health evaluation is rather negative. ANSC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ANSC had positive earnings in the past year.
ANSC had a positive operating cash flow in the past year.
ANSC Yearly Net Income VS EBIT VS OCF VS FCFANSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 2.23%
ROE 2.37%
ROIC N/A
ROA(3y)0.83%
ROA(5y)N/A
ROE(3y)-1.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANSC Yearly ROA, ROE, ROICANSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

ANSC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANSC Yearly Profit, Operating, Gross MarginsANSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ANSC has about the same amount of shares outstanding.
The debt/assets ratio for ANSC is higher compared to a year ago.
ANSC Yearly Shares OutstandingANSC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
ANSC Yearly Total Debt VS Total AssetsANSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 12.28 indicates that ANSC is not in any danger for bankruptcy at the moment.
The Debt to FCF ratio of ANSC is 4.41, which is a neutral value as it means it would take ANSC, 4.41 years of fcf income to pay off all of its debts.
ANSC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 4.41
Altman-Z 12.28
ROIC/WACCN/A
WACCN/A
ANSC Yearly LT Debt VS Equity VS FCFANSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ANSC has a Current Ratio of 0.02. This is a bad value and indicates that ANSC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that ANSC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ANSC Yearly Current Assets VS Current LiabilitesANSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

ANSC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.28%, which is quite impressive.
EPS 1Y (TTM)45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 57.37 indicates a quite expensive valuation of ANSC.
ANSC is valuated expensively when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 57.37
Fwd PE N/A
ANSC Price Earnings VS Forward Price EarningsANSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 2473.73
EV/EBITDA N/A
ANSC Per share dataANSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ANSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGRICULTURE & NATURAL SOLUTI

NASDAQ:ANSC (8/27/2025, 10:31:15 AM)

After market: 11.2 +0.3 (+2.75%)

10.9

+0.02 (+0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-10 2025-11-10
Inst Owners102.26%
Inst Owner Change6.7%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap470.01M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 57.37
Fwd PE N/A
P/S N/A
P/FCF 2473.73
P/OCF 2473.73
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.19
EY1.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.04%
OCF(TTM)0
OCFY0.04%
SpS0
BVpS8.06
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 2.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.83%
ROA(5y)N/A
ROE(3y)-1.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 4.41
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 2.31%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 12.28
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-466.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100%
OCF growth 3YN/A
OCF growth 5YN/A